Clinical characteristics, management, and prognosis of pembrolizumab-induced immune-related oral mucositis
BackgroundPembrolizumab-induced immune-related oral mucositis (irOM) is a rare and often underrecognized toxicity. This study aimed to systematically characterize its clinical profile, histopathologic patterns, management strategies, and outcomes to su…